rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    KURE
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Healthcare ETF: China May Control A Key Bottleneck In AI Drug Discovery
      Oct 22Seeking AlphaKURE
      MRNA Stock Eyes Best Year Ever: Analyst Calls China’s AI Drug Lead ‘Baseless’ As Moderna Awaits Cancer Data
      Sep 28Yahoo FinanceMRNAKURE
      Healthcare ETF: Treatment Breakthroughs Make China A Medical Destination

      During the first half of 2026, Chinese innovative drug developers completed 81 overseas licensing transactions with an aggregate potential deal value of approximately $110 billion.

      Sep 19Seeking AlphaKURE

      This is the newest page. Registered accounts read further back.